Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$727M |
| 3 |
Tesla
TSLA
|
+$402M |
| 4 |
NVIDIA
NVDA
|
+$372M |
| 5 |
AT&T
T
|
+$323M |
Top Sells
| 1 |
Cisco
CSCO
|
+$489M |
| 2 |
Broadcom
AVGO
|
+$428M |
| 3 |
Apple
AAPL
|
+$424M |
| 4 |
Netflix
NFLX
|
+$422M |
| 5 |
CELG
Celgene Corp
CELG
|
+$421M |
Sector Composition
| 1 | Technology | 20.52% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Kennedy-Wilson Holdings
KW
$1.23B
| $32.3M | 0.01% |
1,447,152
+294,747
| +26% | +$6.57M |
|
|
SRCL
902
DELISTED
Stericycle Inc
SRCL
| $32.3M | 0.01% |
505,415
-19,263
| -4% | -$1.23M |
|
|
LOGM
903
DELISTED
LogMein, Inc.
LOGM
| $32.2M | 0.01% |
375,421
-3,676
| -1% | -$315K |
|
904
FibroGen
FGEN
$46.5M
| $32.2M | 0.01% |
29,986
+9,506
| +46% | +$10.2M |
|
905
Progress Software
PRGS
$1.83B
| $32.1M | 0.01% |
773,582
+32,375
| +4% | +$1.35M |
|
906
NCR Voyix
VYX
$1.73B
| $32.1M | 0.01% |
1,486,527
-425,931
| -22% | -$9.19M |
|
|
AMED
907
DELISTED
Amedisys
AMED
| $32M | 0.01% |
191,486
-63,634
| -25% | -$10.6M |
|
908
Pebblebrook Hotel Trust
PEB
$1.36B
| $32M | 0.01% |
1,192,194
-373,412
| -24% | -$10M |
|
909
IDEX
IEX
$12.1B
| $31.9M | 0.01% |
185,655
-63,244
| -25% | -$10.9M |
|
910
XPO
XPO
$15.3B
| $31.9M | 0.01% |
1,157,301
+173,377
| +18% | +$4.78M |
|
911
NeoGenomics
NEO
$966M
| $31.9M | 0.01% |
1,090,324
-47,437
| -4% | -$1.39M |
|
912
Selective Insurance
SIGI
$4.75B
| $31.9M | 0.01% |
488,647
+149,520
| +44% | +$9.75M |
|
913
AGCO
AGCO
$8.02B
| $31.8M | 0.01% |
411,467
-61,807
| -13% | -$4.77M |
|
914
Landstar System
LSTR
$4.5B
| $31.8M | 0.01% |
279,092
+37,417
| +15% | +$4.26M |
|
915
PTC Therapeutics
PTCT
$4.63B
| $31.7M | 0.01% |
660,091
+365,512
| +124% | +$17.6M |
|
916
Murphy USA
MUSA
$7.26B
| $31.7M | 0.01% |
270,721
-33,134
| -11% | -$3.88M |
|
917
Brown-Forman Class B
BF.B
$12.9B
| $31.6M | 0.01% |
468,174
-102,924
| -18% | -$6.96M |
|
918
Trex
TREX
$6.43B
| $31.5M | 0.01% |
701,948
-23,916
| -3% | -$1.07M |
|
919
Neogen
NEOG
$1.21B
| $31.4M | 0.01% |
963,138
-49,780
| -5% | -$1.62M |
|
920
Lear
LEA
$5.76B
| $31.3M | 0.01% |
227,940
-6,518
| -3% | -$894K |
|
921
Sanofi
SNY
$115B
| $31.2M | 0.01% |
620,583
-49,707
| -7% | -$2.5M |
|
922
Plains GP Holdings
PAGP
$3.67B
| $31M | 0.01% |
1,634,324
-555,239
| -25% | -$10.5M |
|
923
DaVita
DVA
$9.46B
| $30.7M | 0.01% |
408,923
+107,342
| +36% | +$8.05M |
|
924
Primerica
PRI
$8.74B
| $30.6M | 0.01% |
234,393
-52,429
| -18% | -$6.85M |
|
925
FIVE9
FIVN
$1.95B
| $30.6M | 0.01% |
466,361
-305,368
| -40% | -$20M |
|